ME/CFS research at Haukeland University Hospital - Norway

Myalgic encephalomyelitis (ME), also known as ME/ CFS (chronic fatigue syndrome), is a complex condition with no known cause. It affects some 0.2 per cent of Norwegians.

Kavli Trust has been supporting work by cancer specialists Olav Mella and Øystein Fluge at Haukeland University Hospital in Bergen, Norway, since 2011.

Their hypothesis is that ME could be an autoimmune condition. 

More about this project

  • Continued backing for ME work

    June 26, 2017

    The Kavli Trust is extending its collaboration over biomedical research on chronic fatigue syndrome or myalgic encephalopathy (ME) at Haukeland University Hospital in Bergen.

  • New study on pathological mechanisms in ME from Bergen research group

    December 22, 2016

    A new study, partly funded by the Kavli Trust, suggests that the PDH enzyme is inhibited in ME/CFS patients, which may explain both energy shortage and increased lactate production in these patients. These findings have now been published in the Journal of Clinical Investigation Insight.

  • Millions of kroner donated for ME research

    September 21, 2015

    Further substantial grants are being made by the Kavli Trust to support promising research on chronic fatigue syndrome or myalgic encephalomyelitis (ME).

  • Tackling a medical mystery

    April 10, 2015

    What exactly is myalgic encephalopathy (ME), also known as chronic fatigue syndrome (CFS), and how can it be treated? Answers to these questions are being sought by cancer specialists at Norway’s Haukeland University Hospital with support from the Kavli Trust.

  • Hope for CFS/ME patients

    October 19, 2011